Skip to content
HowShorted

Arcadia Biosciences, Inc. short interest in 2018

In 2018, Arcadia Biosciences, Inc.'s disclosed short interest ran from 0.90% of shares outstanding on 12 Jan 2018 to 7.27% on 31 Dec 2018, a change of +6.37 percentage points. The year's high was 20.85% on 31 May 2018 and its low 0.90% on 12 Jan 2018, averaging 8.32% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.53 days on 30 Nov 2018. Full history: Arcadia Biosciences, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Arcadia Biosciences, Inc. in 2018

2018 in figures

Start of year
0.90% (12 Jan 2018)
End of year
7.27% (31 Dec 2018)
Change
+6.37 pp
High
20.85% (31 May 2018)
Low
0.90% (12 Jan 2018)
Average
8.32%
Highest days to cover
7.53 (30 Nov 2018)
SEC filings marked
8

Every report in 2018

Arcadia Biosciences, Inc. short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 20180.90%1.00
15 Mar 20184.01%1.00
29 Mar 20188.90%1.0010-K filed, results (8-K)
13 Apr 20188.07%1.00
30 Apr 20185.51%1.00
15 May 201811.20%1.0010-Q filed, results (8-K)
31 May 201820.85%1.00
15 Jun 20188.38%1.00
13 Jul 201817.64%2.66
31 Jul 20188.93%1.00
15 Aug 20188.77%2.8710-Q filed, results (8-K)
31 Aug 20188.57%3.32
14 Sep 20187.81%1.74
28 Sep 20186.09%4.38
15 Oct 20186.19%1.59
31 Oct 20186.78%2.30
15 Nov 20186.99%3.3510-Q filed, results (8-K)
30 Nov 20186.40%7.53
14 Dec 20187.05%1.69
31 Dec 20187.27%1.88

See also: Arcadia Biosciences, Inc.'s full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.